Weight Loss Injections Reviews: What People in the UK Actually Experience

You've read the reviews and they seem to contradict each other, here's why

Search for weight loss injection reviews in the UK and you'll find everything from people describing it as the most significant health change of their adult life to others who stopped after a few weeks because of nausea. Both accounts can be accurate. That apparent contradiction has a straightforward explanation: these medicines are titrated. Treatment with tirzepatide starts at 2.5mg, a dose whose primary job is to help your body adjust, not to drive immediate weight loss. Semaglutide starts at 0.25mg for the same reason. The experience at week two on a starter dose is genuinely different from the experience at month six on a higher one.

People who review weight loss injections early in treatment often lead with side effects. People who review after several months on a stable dose more often lead with results. Neither is wrong; they're describing different points in the same journey. The individual experiences our clinical team sees reflect exactly this pattern, a slow build that rewards patience over the first few weeks.

A question our prescribers hear most weeks is whether nausea means the medicine isn't working or should be stopped. The answer is almost always neither: early GI symptoms are the body responding to a new mechanism, not a sign something has gone wrong. That said, severity matters, and a prescriber should know if symptoms are stopping you from eating or drinking normally.

What the clinical trial results actually showed, and how to read them honestly

The reviews that circulate online are individual experiences. The clinical trials are what give those experiences a broader frame. In the SURMOUNT-1 trial, adults taking the highest tirzepatide dose (15mg) achieved an average body-weight reduction of around 20–21% over 72 weeks, published in the New England Journal of Medicine. In the STEP 1 trial, semaglutide 2.4mg produced an average reduction of around 15% over 68 weeks in adults with obesity.

Those are averages. Some participants lost considerably more; others less. Factors that appear consistently across reviews and trial subgroup data include how closely people stuck to dietary changes alongside the injection, how much they moved, and whether they reached the higher doses or stayed at a lower level because that was enough, or because side effects made titration difficult.

NICE recommended tirzepatide for NHS use in December 2024 (TA1026) and semaglutide earlier under TA875, both assessments concluded the evidence of effectiveness was robust. For people exploring which injection might suit their situation, the trial data is the most reliable starting point, ahead of any individual review.

The side effects people mention most, and what the pattern actually looks like

Across reviews of UK weight loss injections, the side effects that come up most often are nausea, loose stools or constipation, indigestion, and a general feeling of fullness that can make eating feel effortful. Fatigue and mild headaches feature in the earlier weeks for some people. Injection-site reactions (mild redness or tenderness) are occasionally mentioned but rarely described as a lasting problem.

The NHS medicines page for tirzepatide sets out the full side-effect profile clearly, and it is worth reading before starting. What the NHS page reflects, and what people's accounts tend to confirm, is that GI symptoms follow a pattern: more noticeable in the first days after a dose, easing over the following week, and often less pronounced once the body has had several weeks at the same dose level.

Serious side effects are uncommon but exist. Severe stomach pain that extends to the back warrants urgent medical attention, it can be a sign of pancreatitis, which the MHRA highlighted as a known, though infrequent, risk in a January 2026 Drug Safety Update. For anyone unsure whether what they're experiencing is normal adjustment or something that needs prompt review, the right call is always to contact a clinician rather than search for reassurance in reviews. If you want a fuller picture of what costs look like for private treatment, the how much weight loss injections cost page covers what a legitimate price should include.

How to assess a UK weight loss injection review, and when it doesn't apply to you

Not every review of a weight loss injection tells you something useful about your own likely experience. A few things are worth checking before you draw conclusions. First, which medicine and which dose is being described? A review of Wegovy at 0.5mg is a different data point from one at 2.4mg, and tirzepatide reviews at 5mg don't predict what 10mg feels like. Second, how long had the person been on treatment? Third, do they have the same underlying health picture as you, weight-related conditions, other medicines, comparable starting weight?

Reviews from people sourcing injections without a prescription are also worth treating with extra caution. The MHRA has warned repeatedly about counterfeit pens sold online; a review of an unverified product tells you nothing about licensed tirzepatide or semaglutide. Some people also research what others have reported from B12 injections for weight loss, which can be a useful comparison when weighing up different approaches. For a thorough look at what people are actually reporting from regulated UK providers, the reviews of UK weight loss injection providers page is a more grounded place to start than general social media threads.

The most clinically useful reviews are those written by people whose situation closely resembles yours, at doses you might realistically reach, from verified, legitimate sources. If you want to read what patients have said specifically about B12 injections in the context of weight loss, the vitamin B12 injections weight loss reviews page brings together accounts worth reading alongside the GLP-1 evidence. Everything else is interesting background noise. If you're ready to find out whether either medicine is appropriate for you specifically, speaking to our prescribers is the place to start, it's a free consultation, reviewed the same day by a GPhC-registered clinician.